Literature DB >> 10192492

Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.

M Friedrich1, C Villena-Heinsen, D Mink, H Bonkhoff, W Schmidt.   

Abstract

The fourth case of heterologous mesodermal tumour of the uterine corpus, that developed, years following tamoxifen therapy for breast cancer in a postmenopausal woman with no previous pelvic irradiation, is presented with coincidental endometriosis and endometrial intraepithelial carcinoma. This coincidence after tamoxifen treatment appears to be an indication for the possible carcinogenic potency of tamoxifen.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10192492     DOI： 10.1016/s0301-2115(98)00166-3

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN： 0301-2115            Impact factor:   2.435


  10 in total

1.  First documented case of endometrial carcinoma in a patient treated with tamoxifen for encapsulating peritoneal sclerosis.

Authors:  I Juric; N Basic-Jukic; P Kes
Journal:  Perit Dial Int       Date:  2013 May-Jun       Impact factor: 1.756

Review 2.  Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

3.  Primary malignant mixed müllerian tumor of the peritoneum a case report with review of the literature.

Authors:  Fisnik Kurshumliu; Helle Rung-Hansen; Vibeke Ravn Skovlund; Lumturije Gashi-Luci; Thomas Horn
Journal:  World J Surg Oncol       Date:  2011-02-04       Impact factor: 2.754

4.  Women with endometriosis have a higher DNA repair capacity and diminished breast cancer risk.

Authors:  Jaime L Matta; Idhaliz Flores; Luisa M Morales; Janice Monteiro; Carolina Alvarez-Garriga; Manuel Bayona
Journal:  Mol Cancer Biol       Date:  2013-12-20

5.  URI1 amplification in uterine carcinosarcoma associates with chemo-resistance and poor prognosis.

Authors:  Yu Wang; Michael J Garabedian; Susan K Logan
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

6.  Pelvic endometriosis is rarely associated with ovarian borderline tumours, cytologic and architectural atypia: a clinicopathologic study.

Authors:  Mohamed Ali Bedaiwy; Mahmoud Rezk Abd-Elwahed Hussein; Charles Biscotti; Tommaso Falcone
Journal:  Pathol Oncol Res       Date:  2008-06-25       Impact factor: 3.201

7.  Uterine carcinosarcoma/malignant mixed Müllerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy.

Authors:  Brian T Wilson; Heather J Cordell
Journal:  J Gynecol Oncol       Date:  2015-09-23       Impact factor: 4.401

Review 8.  Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives.

Authors:  Salvatore Giovanni Vitale; Antonio Simone Laganà; Stella Capriglione; Roberto Angioli; Valentina Lucia La Rosa; Salvatore Lopez; Gaetano Valenti; Fabrizio Sapia; Giuseppe Sarpietro; Salvatore Butticè; Carmelo Tuscano; Daniele Fanale; Alessandro Tropea; Diego Rossetti
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

9.  Uterine carcinosarcoma: A 10-year single institution experience.

Authors:  Leana Terblanche; Matthys H Botha
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

10.  Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Diagn Pathol       Date:  2008-02-08       Impact factor: 2.644
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.